About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

How Do We Approach Low High-density Lipoprotein Cholesterol in 2011?

Citation:

European Cardiology 2011;7(4):257–63

Managing Dyslipidaemic Patients - Improving Adherence with Lifestyle Intervention

Citation:

European Cardiology 2011;7(4):246–50

Atherosclerosis Plaque Imaging and Characterization Using Magnetic Resonance Imaging

Citation:

US Cardiology 2005;2(1):129-32

Urine Albumin to Creatinine Ratio and Echocardiographic Left Ventricular Structure and Function in Patients with Essential Hypertension

Citation:

American Heart Hospital Journal 2011;9(2):90-4